Top 10 Bioanalytical Services Companies in Apac - 2022
With the outbreak of Covid-19, the bioanalytical services industry experienced high demand and produced market growth opportunities on account of playing a major role in drug investigations and vaccination programs. The market size was estimated at USD 3.64 billion in 2021 and is estimated to grow with a compound annual growth rate of 8.6 percent annually until 2030 and is expected to reach USD 12.34 billion by 2031. In the current scenario, major pharmaceutical companies are focusing on their core competencies and outsourcing R&D in the drug discovery and development process. The economic impact caused by outsourcing, as opposed to conducting an in-house study, acts as a driver and boosts the service demand.
That said, the development of advanced bioanalytical technologies for enhanced testing and commercializing of novel treatments is predicted to augment market growth and generate more revenue opportunities. Various biopharmaceutical companies are utilizing bioanalytical testing outsourcing services for drug development to clinical and preclinical stages, contributing to market growth. Furthermore, the initiation of evolving technologies such as big data and AI into the field is expected to increase demands for the market.
In this edition Life Sciences Review, the magazine focuses on the Top 10 Bioanalytical Services Companies in APAC - 2022, educating on the companies at the front lines of innovation. U-Medico provides high-quality analysis and research services, its Gene and Cell Therapy Division, established in April of 2022 as an example, for biopharmaceuticals and gene therapy drugs. With its 'Two Continent, One System' approach, Frontage Labs aims to provide integrated, science-driven, product development services and helps life-science companies achieve their drug development goals.
Life Sciences Review APAC also brings exclusive insights through our leadership articles, CIOs and CXOs, from Jesper Lekdorf, MD, Sr. Medical Director at Head of Medical Affairs at Novo Nordisk Japan and Roman Mathaes, Head of Pharmaceutical Services and Cristina Grigore, Technical Proposal Manager, Lonza discussing their ideas on current market trends practiced in the industry.
We hope this information on market trends and the viewpoint of thought leaders assist in making informed decisions for your company.










